The value of early and double phase 99tcm-sestamibi scintimammography in the diagnosis of breast cancer

A. Paz; M. Melloul; S. Cytron; R. Koren; G. Ohana; D. Michalevich; R. Gal; Y. Wolloch

doi:10.1097/00006231-200004000-00008

The value of early and double phase ⁹⁹tc^m-sestamibi scintimammography in the diagnosis of breast cancer

A. Paz, M. Melloul, S. Cytron, R. Koren, G. Ohana, D. Michalevich, R. Gal, Y. Wolloch

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Original language	English
Pages (from-to)	341-348
Number of pages	8
Journal	Nuclear Medicine Communications
Volume	21
Issue number	4
DOIs	https://doi.org/10.1097/00006231-200004000-00008
State	Published - 1 Jan 2000
Externally published	Yes

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00006231-200004000-00008

Cite this

@article{76256a13cdeb4a53a8b7a13ef5ac83b0,

title = "The value of early and double phase 99tcm-sestamibi scintimammography in the diagnosis of breast cancer",

author = "A. Paz and M. Melloul and S. Cytron and R. Koren and G. Ohana and D. Michalevich and R. Gal and Y. Wolloch",

year = "2000",

month = jan,

day = "1",

doi = "10.1097/00006231-200004000-00008",

language = "English",

volume = "21",

pages = "341--348",

journal = "Nuclear Medicine Communications",

issn = "0143-3636",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "4",

}

TY - JOUR

T1 - The value of early and double phase 99tcm-sestamibi scintimammography in the diagnosis of breast cancer

AU - Paz, A.

AU - Melloul, M.

AU - Cytron, S.

AU - Koren, R.

AU - Ohana, G.

AU - Michalevich, D.

AU - Gal, R.

AU - Wolloch, Y.

PY - 2000/1/1

Y1 - 2000/1/1

UR - http://www.scopus.com/inward/record.url?scp=0034170312&partnerID=8YFLogxK

U2 - 10.1097/00006231-200004000-00008

DO - 10.1097/00006231-200004000-00008

M3 - Review article

C2 - 10845222

AN - SCOPUS:0034170312

SN - 0143-3636

VL - 21

SP - 341

EP - 348

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

IS - 4